Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MediWound (MDWD) Gross Margin (2016 - 2025)

Historic Gross Margin for MediWound (MDWD) over the last 12 years, with Q3 2025 value amounting to 16.5%.

  • MediWound's Gross Margin rose 9600.0% to 16.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.53%, marking a year-over-year increase of 61100.0%. This contributed to the annual value of 13.03% for FY2024, which is 61200.0% down from last year.
  • Per MediWound's latest filing, its Gross Margin stood at 16.5% for Q3 2025, which was up 9600.0% from 23.51% recorded in Q2 2025.
  • MediWound's 5-year Gross Margin high stood at 70.22% for Q4 2022, and its period low was 8.83% during Q2 2024.
  • Over the past 5 years, MediWound's median Gross Margin value was 23.51% (recorded in 2025), while the average stood at 26.55%.
  • Its Gross Margin has fluctuated over the past 5 years, first surged by 421700bps in 2022, then tumbled by -567500bps in 2023.
  • Quarter analysis of 5 years shows MediWound's Gross Margin stood at 28.05% in 2021, then skyrocketed by 150bps to 70.22% in 2022, then crashed by -81bps to 13.47% in 2023, then grew by 15bps to 15.46% in 2024, then increased by 7bps to 16.5% in 2025.
  • Its Gross Margin stands at 16.5% for Q3 2025, versus 23.51% for Q2 2025 and 18.66% for Q1 2025.